Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Imap: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Imap - General Information

A long-acting injectable antipsychotic agent used for chronic schizophrenia.

 

Pharmacology of Imap

Imap is a relatively long-acting injectable depot antipsychotic drug used for schizophrenia. Imap does not differ greatly from other depot antipsychotics (fluphenazine decanoate, fluphenazine enathate, perphenazine onanthat, pipotiazine undecylenate) with respect to treatment efficacy, response or tolerability. Outcomes suggest that fluspirilene does not differ significantly from oral antipsychotics or in different weekly regimens, although much cannot be inferred because of the shortage of trials.

 

Additional information about Imap

Imap Indication: Used for the treatment of schizophrenia. Mechanism Of Action: Not Available Drug Interactions: Not Available Food Interactions: Avoid alcohol. Generic Name: Fluspirilene Synonyms: Fluspirileno [inn-spanish]; Fluspirilenum [inn-latin] Drug Category: Antipsychotic Agents; Dopamine Antagonists Drug Type: Small Molecule; Approved Other Brand Names containing Fluspirilene: Imap; Lopac-F-100; Redeptin; Absorption: Not Available Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Not Available Half Life: Not Available Dosage Forms of Imap: Solution Intramuscular Chemical IUPAC Name: 8-[4,4-bis(4-fluorophenyl)butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one Chemical Formula: C29H31F2N3O Fluspirilene on Wikipedia: https://en.wikipedia.org/wiki/Fluspirilene Organisms Affected: Humans and other mammals